CEL SCI CORP
Clinical-stage biotech developing immunotherapies for cancer and infectious diseases.
CVM | US
Overview
Corporate Details
- ISIN(s):
- US1508377066
- LEI:
- Country:
- United States of America
- Address:
- 8229 BOONE BLVD ., 22182 VIENNA
- Website:
- https://cel-sci.com/
Description
CEL-SCI Corporation is a clinical-stage biotechnology company engaged in the research and development of immunotherapies for cancer, autoimmune, and infectious diseases. Its lead investigational therapy, Multikine (Leukocyte Interleukin, Injection), is a neoadjuvant treatment designed to stimulate a patient's immune system to fight cancer before standard treatments like surgery, radiation, and chemotherapy are administered. The company has completed a global pivotal Phase III clinical trial for Multikine in patients with advanced primary, previously untreated squamous cell carcinoma of the head and neck. The study demonstrated a significant 5-year overall survival benefit in a specific patient subgroup. CEL-SCI is also developing its LEAPS (Ligand Epitope Antigen Presentation System) technology platform for potential treatments of autoimmune and infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-05 14:48 |
PRIMARY DOCUMENT
|
English | 6.8 KB | ||
| 2025-12-04 06:15 | English | 5.2 KB | |||
| 2025-11-24 23:00 |
FORM 8-K
|
English | 232.2 KB | ||
| 2025-11-07 22:31 |
FORM S-3
|
English | 139.1 KB | ||
| 2025-11-05 22:31 |
FORM 8-K
|
English | 227.0 KB | ||
| 2025-10-02 22:01 |
PRIMARY DOCUMENT
|
English | 6.5 KB | ||
| 2025-10-02 21:57 |
PRIMARY DOCUMENT
|
English | 6.5 KB | ||
| 2025-10-02 21:46 |
PRIMARY DOCUMENT
|
English | 6.5 KB | ||
| 2025-08-29 22:16 |
FORM S-8
|
English | 476.9 KB | ||
| 2025-08-29 19:15 |
FORM 8-K
|
English | 297.5 KB | ||
| 2025-08-29 15:00 | English | 8.2 KB | |||
| 2025-08-28 22:24 |
424B5
|
English | 993.1 KB | ||
| 2025-08-27 23:25 |
424B5
|
English | 1004.4 KB | ||
| 2025-08-23 00:00 |
FORM 8-K
|
English | 55.4 KB | ||
| 2025-08-14 15:31 |
FORM 10-Q
|
English | 1.4 MB |
Automate Your Workflow. Get a real-time feed of all CEL SCI CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CEL SCI CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CEL SCI CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
